- 2025-12-16
- New Product | SDR9001: NeoLNP™ Ultra Antibody-Conjugated ctLNP Kit – Effortlessly Master RNA Del...
NeoLNP™ Ultra Antibody-Conjugated ctLNP Kit (for Primary Human T Cells) SDR9001 is a ready-to-use lipid nanoparticle suspension designed for efficient RNA transfection in primary human T cells.
-
- 2025-06-05
- Scindy Pharmaceutical and GENESEED Biotechnology have reached a strategic cooperation to jointly explore new frontiers in circRNA LNP therapy...
- On June 4, 2025, Sundy Biotechnology (Suzhou) Co., Ltd. (hereinafter referred to as "Sundy Bio") and Guangzhou Genesail Biotechnology Co., Ltd. (hereinafter referred to as "Genesail Bi...
-
- 2025-03-27
- Scindy Pharmaceutical invites you to attend the 6th bionnova biomedical innovators' Forum and exhibition and meet with Zhangjiang Science Hall in Shangha...
- Scindy Pharmaceutical (Suzhou) Co., Ltd. is a high-tech enterprise with independent innovation of nano carriers as the core. It is committed to promoting the basic research and clinical transfor...
-
- 2024-11-27
- Scindy Pharmaceutical: Advanced delivery technology accelerates the development of innovative therapies such as RNA...
- Scindy Biopharmaceutical (Suzhou) Co., Ltd. is a research and development platform enterprise with independent innovation of nanocarriers as its core....
-
- 2024-08-08
- Scindy Pharmaceutical with Yanyin Technology to expand into new fields of synthetic biology...
- Recently, Scindy Pharmaceutical (Suzhou) Co., Ltd. (hereinafter referred to as "Scindy Pharmaceutical") and Shanghai Yanyin Technology Co., Ltd. (hereinafter referred to as "Yanyin Tech...
-
- 2023-12-05
- Scindy Pharmaceutical and Levostar Forge Strategic Partnership in “mRNA-LNP” Field...
- On November 30, 2023, Scindy Pharmaceuticals (Suzhou) Co., Ltd. (hereinafter referred to as “Scindy Pharmaceutical”) and Levostar Life Sciences (Suzhou) Co., Ltd. (hereinafter referre...
-
- 2023-11-15
- Scindy Pharmaceutical has entered into a strategic partnership with GenePharma
- On November 14, 2023, Scindy Pharmaceutical (Suzhou) Co., LTD. (hereinafter referred to as "Scindy Pharmaceutical") announced a strategic cooperation with Suzhou Gene Pharma Co., LTD...
-
- 2023-09-25
- Our three NeoLNP™ transfection kits have just hit the market!
- LNP, represented by non-viral vectors, serves not only as a vital tool in life sciences for gene-related research but also as the cornerstone technology for innovative therapies such as RNA ther...
-
- 2023-09-27
- The 8th China Pharmaceutical Innovation and Investment Conference was held in Suzhou...
- On the 25th of May, the 8th China Medical Innovation and Investment Conference was held in Suzhou Industrial Park. He Wei, Vice Chairman of the 14th National People's Congress Standi...
-
- 2023-09-18
- Shanghai Municipal Science and Technology Commission and others on the issuance of the Action Plan for Promoting Gene Therapy Scientific and Technol...
- Notice on issuing Shanghai Action Plan for Promoting Scientific and Technological Innovation and Industrial Development of Gene Therapy (2023-2025)...
-
- 2023-08-25
- Li Qiang presided over the executive meeting of The State Council to review and adopt the Action Plan for High-quality Development of the Pharmaceutic...
- Beijing, Aug. 25, Xinhua News Agency On August 25, Premier Li Qiang presided over an executive meeting of The State Council to review and adopt the Action Plan for High-quality Develo...
